Tianhu Sun

I am interested in plant secondary metabolism, metabolic engineering, and plant molecular farming. Currently I am focusing on revealing carotenoid biosynthesis using tomato and Arabidopsis as model systems and multiple vitamin biofortification in seeds using synthetic biology and genetic engineering methods. Another research topic of my lab is using plant system to produce therapeutic proteins.

Tamara Mandell

Tamara Mandell, M.Ed., serves as Director of Biotility at the University of Florida (UF Biotility), where she leads national efforts to build a skilled, future ready bioscience workforce. Applying more than a decade of combined academic research and industrial biotechnology experience, she leads with a pragmatic approach to aligning competencies and skills with regulated manufacturing and research environments. Tamara led the development of the Biotechnology Aptitude and Competency Exam (BACE), a nationally recognized credential that provides employers with validated measures of workforce ready skills and expands pathways into biotechnology careers. A champion for learners, instructors, and the broader bio industrial community, she seeks to embed industry practices, competencies, and skills into multi-level curricula to support a talent pipeline capable of contributing to engineering biology and biomanufacturing innovation.
She oversees Biotility’s portfolio of industry recognized, ISO/IEC 17024 aligned credentials, developed with biotechnology employers and governed by a national industry advisory board to ensure rigor and continued relevance. Her leadership focuses on stackable credentials with cross-cutting standards leading to increased career options and advancement across biotechnology sectors. A strong advocate for maintaining high standards while expanding access, Tamara emphasizes the role of validated credentials in strengthening employer–education alignment and supporting a safe, ethical, and well qualified biotechnology workforce. Tamara holds a B.S.E. in Biology and a Master of Education in Curriculum and Instruction, foundations that bridge scientific expertise with evidence based educational design. This combination drives her commitment to shaping a capable, credentialed, and forward-looking bioscience workforce equipped to support the responsible growth and innovation goals of the broader bioscience industries.

David Gillum

Dr. David Gillum is Associate Vice President for Compliance and Research Administration and Adjunct Faculty in the School of Public Health at the University of Nevada, Reno. With more than 30 years of experience, he has led diverse teams across higher education and professional associations, and is widely recognized for his expertise in biosafety, biosecurity, compliance, risk management, and research administration. His research interests focus on the social and ethical dimensions of emerging technologies, including artificial intelligence, biotechnology governance, dual-use research of concern, and potential pandemic pathogens. He has published extensively in outlets such as Science Magazine, StatNews, Frontiers in Bioengineering and Biotechnology, mSphere, Applied Biosafety and Health Security. A former President of ABSA International (2020), Dr. Gillum has received several recognitions including the FBI Director’s Community Leadership Award (2019) and the ABSA International Everett Hanel, Jr. Presidential Award (2024). He is dedicated to fostering collaboration, innovation, and continuous improvement in support of research, education, and public service.

Webinar – Relational Governance for Engineered Organisms

In this lecture, Riley Taitingfong, Ph.D., Postdoctoral Fellow at University of Arizona, will focus on practical tools and frameworks for supporting Indigenous governance of emerging biotechnologies, with particular relevance for engineered microbes for environmental release (EMERs). Drawing on concepts and strategies from the Indigenous Data Sovereignty movement, Taitingfong will show how governance approaches rooted in connectivity, reciprocity, and responsibility to place can translate into concrete guidance for actors exploring the use of engineered microbes in the environment. By situating EMERs within relational governance approaches, Taitingfong asks how decision-making processes can align scientific objectives with local priorities while accounting for power imbalances and honoring long-held relationships to lands, waters, and more-than-human kin. Taitingfong will introduce tools to demonstrate how Indigenous governance frameworks can be operationalized in practice. Together, we will consider how these tools offer pathways for integrating relational accountability into EMER development and supporting community-driven approaches to biotechnology.

Internship at The White House Office of Science and Technology

Posted: 02/05/2026

About the Company/Organization:

The White House Office of Science and Technology
Type: Other
Size:
https://www.whitehouse.gov/ostp/

Congress established the Office of Science and Technology Policy (OSTP) in 1976 to provide the President and Executive Office of the President (EOP) with advice on the scientific, engineering, and technological aspects of national policy and the work of the executive branch. This includes matters of the economy, national security, homeland security, health, foreign relations, the environment, education, and resource management.

The OSTP Director oversees the development and execution of the nation’s science and technology policy agenda, leading White House efforts in critical and emerging technologies such as artificial intelligence, quantum information sciences, and biotechnology, with the aim of safeguarding US leadership in these fields and ensuring they advance in ways that bolster American economic competitiveness, national security, and human flourishing. The OSTP Director co-chairs the President’s Council of Advisors on Science and Technology (PCAST), an advisory board whose members are drawn from outside the Federal Government, typically from industry, academia, and research institutions. The Director also chairs the National Science and Technology Council (NSTC), which coordinates the science and technology policymaking process across the executive branch to ensure delivery of the President’s agenda.

In addition to leading interagency science and policy coordination, OSTP assists the Office of Management and Budget (OMB) with annual reviews and priority setting for the Federal research and development budget, and evaluates the scale, quality, and effectiveness of Federal science and technology efforts. OSTP also serves as a source of scientific and technical analysis and judgment for the President with respect to any major strategies, plans, and Government programs.


Internship Project/Opportunity

Location: Washington DC
Anticipated internship dates: Year round
Target intern experience level: Undergraduate Students, Graduate Students
https://www.whitehouse.gov/ostp/internships/

The White House Office of Science and Technology Policy Internship Program

Serving as an OSTP Intern provides students a unique opportunity to work closely with senior White House officials and science and technology staff in OSTP’s policy divisions or on OSTP’s legal team.

More information about the application process can be found here: https://www.whitehouse.gov/wp-content/uploads/2026/01/OSTP-Intern-2026-Guidance.pdf

Policy Internships
Students interested in working on the development of national science and technology policy are recommended to apply for a policy internship. Ideal candidates have a passion for science and technology, strong research and writing skills, the ability to work while prioritizing several projects at once, a willingness to support outreach events and a desire for public service. Policy internships are open to interested students from all majors and academic programs. Any student, including law students, may apply for a policy internship.

Internships are also available with OSTP’s communications team. Students interested in Communications or Public Affairs should inquire about opportunities to work primarily with OSTP’s communications team in their policy application.

Policy internship applications only should be sent to: internships@ostp.eop.gov
Questions about your policy internship application should be sent to: internships@ostp.eop.gov

Eligibility
All applicants must be U.S. citizens. Permanent residents and students who do not currently hold U.S. citizenship are not eligible.
Applicants must be enrolled, at least half-time, in an accredited college or university during the desired internship term. Students in undergraduate, graduate, law, LLM, and professional programs in all fields are encouraged to apply.
Preference will be given to applicants available for 30+ hours per week.

Timeline
Summer Semester (May – August): Applications due February 28, 2026
Fall Semester (September – December): Applications due June 14, 2026
Spring Semester (January – April): Applications due September 20, 2026

Contact: Email

Robert Mikulak

Ambassador (ret) Robert P. Mikulak is an independent expert on chemical and biological security issues. Until mid-December 2025, he served as an expert on these issues at the United States Department of State, focusing on measures for strengthening the Biological Weapons Convention, ensuring that advances in biology are not used to create new biological weapons, and investigation of alleged use of chemical or biological weapons. He is also an expert consultant for the UN Office of Disarmament Affairs.
From November 2010 until his retirement in July 2015, Ambassador Mikulak was the United States Permanent Representative to the Organization for the Prohibition of Chemical Weapons (OPCW). He previously served in the State Department and the U.S. Arms Control and Disarmament Agency in a series of increasingly responsible technical and policy positions related to prohibition of chemical and biological weapons. During the decade-long negotiation of the 1992 Chemical Weapons Convention, he was the deputy U.S. negotiator and senior U.S. expert.
Ambassador Mikulak was awarded the OPCW-The Hague Award in 2019 for outstanding contributions toward a world free of chemical weapons. Other honors include high-level awards from the Secretaries of State and Defense and the American Association for the Advancement of Science.
Ambassador Mikulak received his undergraduate degree in chemistry at Hamline University in St. Paul, Minnesota and his Ph.D. in organic chemistry from the Massachusetts Institute of Technology. He did post-doctoral research at the Max Planck Institute for Biophysical Chemistry in Göttingen, Germany and the Massachusetts Institute of Technology.

Allen Liu

Allen Liu received a B.Sc. degree in Biochemistry (Honors) from the University of British Columbia in 2001. He obtained his Ph.D. in Biophysics in 2007 from the University of California-Berkeley and received his post-doctoral training at The Scripps Research Institute-La Jolla. He started his group in 2012, and he is currently the Associate Chair for Graduate Education and a Professor in Mechanical Engineering, Biomedical Engineering, and Biophysics at the University of Michigan. His current research interests lie in cellular mechanotransduction and bottom-up synthetic biology, and his lab uses tools from quantitative cell biology, synthetic biology, biophysics, and microfluidics. He has received the NIH Director’s New Innovator Award, a Young Innovator by Cellular and Molecular Bioengineering (CMBE), a Rising Star from CMBE-Biomedical Engineering Society (BMES), and was named a Future of Biophysics Burroughs Wellcome Fund Symposium speaker. He is an elected Fellow of the BMES, and a recipient of the Endeavour Executive Fellowship (Australia) and the Alexander von Humboldt Fellowship for Experienced Researcher (Germany)

Synthetic Biology and Engineering Organisms for the Environment

What are engineered microbes? How are they created? And why are scientists developing them? In this lecture, Joff Silberg, Ph.D., Professor of Biosciences at Rice University, will describe what synthetic biology is and how it can be used to develop engineered microbes that have new functions that can identify disease outbreaks, breakdown chemicals, and develop more sustainable fertilizers.

This event is part of the “Engineered Microbes for Environmental Release” webinar series that brings together voices from synthetic biology, ecology, policy, science and technology studies, biotechnology, ethics, and history to explore the social, technological, and environmental dimensions of these innovations. Hosted by the Baker Institute’s Science and Technology Policy Program and co-sponsored by the Rice Synthetic Biology Institute, this webinar series was supported by a grant from Schmidt Sciences and the National Science Foundation (#2223678 & 2515431).

Alejandro Vallejo

I am a biotechnologist and biosecurity specialist with active research and policy engagement at the intersection of synthetic biology, public health, and regulatory governance. My work combines molecular biology, genomics, and bioethics with the development and evaluation of biosafety and biotechnology regulatory frameworks in Latin America and the Caribbean. I have published peer-reviewed research on genomics, molecular diagnostics, and emerging biotechnologies, and I served as a national consultant on biosecurity for international organizations including FAO and PAHO/WHO and National organizations like the Ministry of Environment. My professional focus is on enabling responsible innovation in synthetic biology through evidence-based policy, capacity building, and applied research in resource-limited settings.

Rennos Fragkoudis

Rennos Fragkoudis completed his PhD on molecular virology and viral pathogenesis at the University of Edinburgh and for ~15 years he concentrated his research on the pathogenesis of arthropod-borne viruses (arboviruses) in both vertebrate and invertebrate systems working with alpha-, flavi- and bunyaviruses.
Since November 2019, Rennos is the Head of the Edinburgh Genome Foundry at the University of Edinburgh’s School of Biological Sciences. In this role, he leads a multidisciplinary team focused on advancing high-throughput Engineering Biology through the innovative application of laboratory automation and robotics. Under his leadership, the Edinburgh Genome Foundry has become a hub for automated Engineering Biology, fostering collaboration across academia and industry and working on a large variety of projects addressing grand challenges.

Susan Rosser

Susan is Professor of Synthetic Biology and Royal Academy of Engineering (RAEng) Chair in Emerging Technologies at the University of Edinburgh. She was Director of the UK Centre for Mammalian Synthetic Biology and is currently the director of the newly funded Engineering Biology Mission Hub for Advanced Therapeutics. Prof Rosser is Co-director of the Edinburgh Genome Foundry for synthetic DNA assembly and cell phenotyping. Her research focuses on using engineering biology approaches for developing and controlling genetic circuits for applications in cell and gene therapies as well as metabolic engineering. Prof Rosser is a member of the UK Engineering Biology Advisory Panel. She is also co-founder of two early-stage start-ups using a combination of AI and engineering biology for new gene therapies and enzyme replacement therapies for rare diseases.

Seung Hwan Lee

Seung Hwan “Allen” Lee is an Assistant Professor of Chemical Engineering and Materials Science and Ray D. & Mary T. Johnson/Mayon Plastics Professor at the University of Minnesota, Twin Cities. His passion for engineering microorganisms to enable sustainable energy and chemical production began during his undergraduate research at UCLA under Prof. James Liao. After completing his undergraduate studies, he earned his Ph.D. in Chemical and Biomolecular Engineering from Rice University, where he worked under the guidance of Prof. Ramon Gonzalez. His undergraduate and doctoral research focused on the efficient biological utilization of one-carbon (C1) compounds through engineering native and synthetic metabolic pathways. As one of the co-inventors of the Formyl-CoA Elongation (FORCE) pathways, he helped develop a novel approach for converting C1 feedstock into value-added small molecules. During his postdoc under the guidance of Prof. Greg Stephanopoulos at MIT, he has expanded his research to include engineering non-model organisms, leveraging their inherent abilities to efficiently utilize C1 and C2 feedstocks. Beyond his research, Allen is actively engaged in biotechnology and climate technology communities, participating in organizations such as the Society for Industrial Microbiology and Biotechnology (SIMB), the Engineering Biology Research Consortium (EBRC), and the MIT Energy Conference.

Rodrigo Ledesma-Amaro

Rodrigo Ledesma-Amaro is a Professor at Imperial College London, where he leads a research group working on Engineering Biology and sustainability. He is the director of the Bezos Centre for Sustainable Proteins and the Microbial Food Hub. His research focuses on the use of microorganisms to convert renewable feedstocks into valuable products (such as food ingredients). He has published over 200 articles, most on topics related to microbial bioproduction (precision, biomass and traditional fermentation).
Rodrigo obtained his PhD at the University of Salamanca (Spain). Before joining Imperial, he carried out his postdoctoral research at the National Research Institute for Agriculture, Food and the Environment (INRAE, France). He has been a visiting researcher at Chalmers University of Technology (Sweden) and AIST (Japan).

Joshua Wentzel

Josh Wentzel is the Assistant Director of the Biosecurity and Pandemic Policy Center, part of the Scowcroft Institute for International Affairs at the Texas A&M Bush School of Government & Public Service.​ Based at the Bush School DC, Josh has six years of experience working in Congress, where he spent time in both chambers, working in the House and on the Senate Committee on Health, Education, Labor and Pensions (HELP) working on pandemic preparedness, stockpiling, and biosecurity issues. During the COVID-19 pandemic response, Josh joined the U.S. Department of Health and Human Services, working closely with the Assistant Secretary for Preparedness and Response (ASPR) on distribution of COVID-19 medical countermeasures, daily situational awareness reports, and ASPR testimony to Congress and communication with State and Local governments. He holds a BA in International Studies from Emory University and an MS in Biohazardous Threat Agents and Emerging Infectious Diseases from Georgetown University.

Mark Bathe

Mark Bathe is a Professor in the Department of Biological Engineering at MIT, a Member of the Harvard Medical School Initiative for RNA Medicine, and an Associate Member of the Broad Institute of MIT & Harvard. He obtained his Doctoral Degree at MIT working in the Departments of Biological, Chemical, and Mechanical Engineering before moving to the University of Munich for his postdoctoral research in Biological Physics. He returned to MIT in 2009 to join the faculty in the Department of Biological Engineering, where he runs an interdisciplinary research group focused on engineering nucleic acids for the targeted delivery of therapeutics and vaccines, phenotypic profiling of neuronal circuits, and molecular computing and data storage. He is academic co-founder of Cache DNA and Kano Therapeutics, and in his free time he enjoys running, biking, swimming, and skiing, amongst other outdoor activities.

Xu Zhang

Dr. Zhang’s work integrates genetic engineering, electrochemistry, and device design to develop living microbial systems for bioelectronics and functional biomaterials.

Christian Euler

I am a metabolic engineer and systems biologist with research interests primarily focused on finding/developing novel biological pathways for waste upcycling. My group does “full stack” metabolic engineering, from in silico modelling and design through to bench-scale fermentation to evaluate scalability. I am also the co-founder of Phycus Biotechnologies, which makes bio-based glycolic acid using a novel, sustainable fermentation process.

NextGen Omics, Spatial & Data UK 2025

The NextGen Omics, Spatial & Data UK event, now in its 18th year, unites the multi-omics, spatial biology, and data science communities. Held annually in London, it serves as a key meeting point for influential researchers, healthcare leaders, and technology innovators from the UK and Europe. The event aims to address the complexity of interpreting and integrating multi-omics data by fostering dialogue, sharing best practices, and inspiring cross-sector collaboration among teams from academia, pharma, and biotech, ultimately aiming to accelerate the development of life-saving treatments for patients.

Alberto Donayre

Dr. Alberto J. Donayre-Torres is a Professor in the Department of Bioengineering at Universidad de Ingeniería y Tecnología (UTEC) in Lima, Peru. He holds a Ph.D. in Plant Genetics and Biotechnology from CINVESTAV-IPN, Mexico (2009), and completed postdoctoral training at the National Autonomous University of Mexico (UNAM) and Colorado State University (USA), where he spent five years advancing synthetic biology platforms for programmable biological systems. His research sits at the convergence of synthetic biology, advancing biomaterials using bioconjugation engineering (ACS Omega, 2025). He leads projects developing open-source tools for DNA assembly (pyBrick-DNA, J. Comp. Biol., 2023) and develops international collaboration on predictive biomaterial modeling AI-assisted. Dr. Donayre has supervised undergraduate and graduate research in recombinant protein synthesis, hydrogel functionalization, and bioconjugation — and actively contributes to the global synthetic biology community as co-organizer of international congresses and developer of open bioengineering platforms.

Joy Y. Zhang

Joy Y. Zhang is a Professor of Sociology and Founding Director of the Centre for Global Science and Epistemic Justice (GSEJ) at the University of Kent. Her research examines evolving science–society dynamics and their implications for the global ethical governance of emerging life sciences. Conceptually, her work advances the theorisation of cosmopolitanisation, decolonisation, commoning, epistemic justice, and subaltern politics. Empirically, her research focuses on four major scientific powers—China, India, the UK, and the US. She has studied the governance and science diplomacy of emerging life sciences—including stem cells, synthetic biology, genome editing, and experimental therapies—alongside climate politics, food movements, and environmental engineering. She currently leads three cutting-edge social research programmes on engineering biology and its applications in critical minerals, biomedicine, and agriculture, with the aim of informing social and policy deliberation in the UK and internationally. She is the author of three academic books and publishes widely in high-impact journals across the natural and social sciences. She is frequently interviewed by global media and advises leading research and policy institutions in Europe and Asia.